Yunnan Baiyao Group Co.,Ltd

Shenzhen Stock Exchange 000538.SZ

Yunnan Baiyao Group Co.,Ltd Net Income for the year ending December 31, 2023: USD 576.61 M

Yunnan Baiyao Group Co.,Ltd Net Income is USD 576.61 M for the year ending December 31, 2023, a 32.59% change year over year. Net income is the total profit earned by a company after deducting all expenses, including taxes and non-controlling interest.

Yunnan Baiyao Group Co.,Ltd Net Income for the year ending December 31, 2022 was USD 434.89 M, a -1.48% change year over year.
Yunnan Baiyao Group Co.,Ltd Net Income for the year ending December 31, 2021 was USD 441.44 M, a -47.76% change year over year.
Yunnan Baiyao Group Co.,Ltd Net Income for the year ending December 31, 2020 was USD 845.06 M, a 40.66% change year over year.
Yunnan Baiyao Group Co.,Ltd Net Income for the year ending December 31, 2019 was USD 600.78 M, a 24.96% change year over year.

Key data

Date	Net Income	EPS (Diluted)	Shares (Diluted, Weighted)	Net Income Margin

Shenzhen Stock Exchange: 000538.SZ

Yunnan Baiyao Group Co.,Ltd

CEO	Mr. Ming Dong
IPO Date	Dec. 15, 1993
Location	China
Headquarters	No. 3686, Yunnan Baiyao Street
Employees	8,834
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

Yunnan Baiyao Group Co.,Ltd engages in the pharmaceutical business in China and internationally. It provides health products, drugs, medical instruments, Chinese medicine resources, and tea. The company offers its products under the Yunnan Baiyao, Yunfeng, Tong Qiaoqiao, Yunjian, Life, Jinkoujian, Langjian, Yangyuanqing, Caizhiji, Baiyao Health, Leopard Seven, Qiancaotang, Qiancao Meizi, and Tianzihong brand names. Yunnan Baiyao Group Co., Ltd. was founded in 1902 and is based in Kunming, China.

Key trends

Past 5 years